key: cord-0817351-nyh6ro2m
authors: Massimo, Torreggiani; Hafedh, Fessi; Barbara, Piccoli Giorgina
title: On the need to better protect hemodialysis patients. A comment on “IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)”.
date: 2021-01-11
journal: Kidney Int
DOI: 10.1016/j.kint.2020.11.024
sha: 5586bf46cb915b8961e38503afb9583f1b269204
doc_id: 817351
cord_uid: nyh6ro2m

nan

On the need to better protect hemodialysis patients. A comment on "IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)". We read with interest the IMPORTANT study, focused on the impact that COVID-19 has had on dialysis and transplant patients. 1 The authors report that 44% and 42% of the deaths recently recorded in kidney transplant recipients and dialysis patients candidates for transplantation, respectively, are attributable to COVID-19 and clearly show that these deaths are in excess over the mortality observed in the previous year. Interpreting these results, the authors are in favor of maintaining kidney transplant activity, at least in areas of low viral circulation, to remove patients from the dialysis pool and thereby protect them from the excess mortality related to dialysis. While agreeing with the importance of maintaining transplant programs, we would like to draw attention to a complementary reading of the results. In fact, 122 deaths after kidney transplantation and 60 in waitlisted patients when considering 606 and 478 COVID-19 diagnoses respectively, correspond to 19.5% mortality in kidney transplant patients and 12.5% in waitlisted patients found to be SARS-CoV-2 positive. This mortality rate is consistent with previous reports on kidney transplant recipients (about 22.8%) 2 and is even lower compared with the overall mortality in COVID-19 patients on dialysis (about 20%) 3 in the same country in the same period, even in areas of high-viral circulation. 4 The lower mortality in waitlisted dialysis patients is presumably due to the positive selection of these cases.

It is noteworthy that the cumulative incidence of SARS-CoV-2 positivity was almost double in waitlisted patients compared to kidney transplant recipients (2.95% in waitlisted patients J o u r n a l P r e -p r o o f vs 1.46% after kidney graft) and this difference is still being found during the second wave of the pandemic (6.3% in the overall dialysis population vs 2.3% in kidney transplant patients), according to the latest data published by the French Agency of Biomedicine, on November 9, 2020.

The excess of mortality in dialysis observed during the first COVID-19 pandemic wave was therefore not due to a different viral aggressiveness but depended on the higher risk of becoming infected. Hemodialysis patients are compelled to come to the hospital for renal replacement therapy and cannot be confined at home, thus multiplying occasions for contagion; the risk exposure is not shared only by the relatively few home-dialysis patients. 5 More frequent contact with a hospital was in fact also considered as one of the reasons for a higher death risk in the first year after kidney transplantation.

In parallel to the suggestions regarding kidney transplant activity, we believe that the data reported clearly underline the need for optimizing protection of hemodialysis patients, trying also to identify the best strategies for personal protection, screening and follow-up of positive cases. Development of home-based dialysis, whose advantages have been demonstrated, in particular in areas of high viral circulation 6 , is probably the best long-term strategy effective not only in increasing patient empowerment, adherence and perhaps survival, but also in protecting our fragile population from present and future epidemic outbreaks.

IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)

An initial report from the French SOT COVID Registry suggests high mortality due to Covid-19 in recipients of kidney transplants

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

COVID-19 in Patients on Maintenance Dialysis in the Paris Region

The COVID-19 infection in dialysis: are home-based renal replacement therapies a way to improve patient management?

Home hemodialysis during the COVID-19 epidemic: comment on the French experience from the viewpoint of a French home hemodialysis care network